THOUSAND OAKS BIOPHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Jan 2022)
What this means for you
This application is over — abandoned 03 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88827227
- Mark type
- Design + words
- Filed
- 09 Mar 2020
- Published for opposition
- 06 Oct 2020
- Abandoned
- 03 Jan 2022
- Attorney of record
- Max Vern
Goods and services
- Class 042 — Scientific and technological services: Technological research in the field of computer hardware systems; research and development of new products for others; scientific laboratory services; biological research; material testing; development of pharmaceutical preparations and pharmaceuticals; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation, namely, drug evaluation; medical research
Owner
- THOUSAND OAKS BIOPHARMA (NANTONG) CO., LTD., NANTONG, JIANGSU, CN
- Thousand Oaks Biopharma (Haimen) Co., Ltd., Haimen Nantong Jiangsu, CN
- Thousand Oaks Biopharma (Haimen) Co., Ltd., Haimen Nantong Jiangsu, CN
Prosecution history
- 03 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 13 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 May 2021 — SOU EXTENSION 1 GRANTED
- 11 May 2021 — SOU EXTENSION 1 FILED
- 11 May 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2020 — POST PUBLICATION AMENDMENT – NOT ENTERED
- 21 Oct 2020 — ASSIGNED TO PETITION STAFF
- 06 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Oct 2020 — PUBLISHED FOR OPPOSITION
- 16 Sept 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 31 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER